Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?

Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?

Addiction (2019)

Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?

English
PDF
In Amsterdam, HIV prevalence has nearly halved among injecting drug users (IDU) since 1990. Hepatitis C virus (HCV) prevalence also declined; HIV and HCV incidence dropped to nearly zero. We examined possible explanations for these time trends, among which the implementation of harm reduction measures aimed at reducing the risk behaviour of IDU.
The selected activity requires you to open a PDF document from an external website.
Click the button below to open the requested document in a new browser tab or window.
To return to this page, switch back to this browser tab, or close the newly opened page.
Open "Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?"
In partnership with:
ISFF
FUAS
Correlation Network